Literature DB >> 8151308

Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine.

S A Wharton1, R B Belshe, J J Skehel, A J Hay.   

Abstract

The anti-influenza virus drug amantadine was shown to reduce the rate of fusion of liposomes with influenza A viruses whose replication is inhibited by this drug. The fusion with amantadine-resistant viruses was unaffected. Experiments with reassortant and mutant viruses showed that this effect was linked to the M2 protein and not to the haemagglutinin of the virus. The proton ionophore monensin, on the other hand, substantially increased the rate of fusion of the viruses tested. These results indicate that the kinetics of virus-liposome fusion can be modulated by the virus M2 protein, the target of amantadine action, and it is postulated that the M2 ion channel functions by transporting protons into the virion interior and facilitating virus uncoating.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151308     DOI: 10.1099/0022-1317-75-4-945

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  33 in total

1.  Assembly of the m2 tetramer is strongly modulated by lipid chain length.

Authors:  Sandra Schick; Lirong Chen; Edwin Li; Janice Lin; Ingo Köper; Kalina Hristova
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

2.  Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity.

Authors:  L R Hoffman; I D Kuntz; J M White
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus.

Authors:  Travis R Ruch; Carolyn E Machamer
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

4.  At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane.

Authors:  Juan Fontana; Alasdair C Steven
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

Review 5.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

Review 6.  Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.

Authors:  Yanmei Hu; Hannah Sneyd; Raphael Dekant; Jun Wang
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

7.  Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel.

Authors:  Victoria Balannik; Vincenzo Carnevale; Giacomo Fiorin; Benjamin G Levine; Robert A Lamb; Michael L Klein; William F Degrado; Lawrence H Pinto
Journal:  Biochemistry       Date:  2010-02-02       Impact factor: 3.162

Review 8.  The biology of influenza viruses.

Authors:  Nicole M Bouvier; Peter Palese
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

9.  Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.

Authors:  S J Plotch; B O'Hara; J Morin; O Palant; J LaRocque; J D Bloom; S A Lang; M J DiGrandi; M Bradley; R Nilakantan; Y Gluzman
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Prolidase is required for early trafficking events during influenza A virus entry.

Authors:  Marie O Pohl; Thomas O Edinger; Silke Stertz
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.